gut.bmj2d
The role of gut microbiota in cancer treatment: friend or foe?
Correspondence to Dr Jun Yu, Institute of Digestive Disease and The Department of Medicine and Therapeutics, Chinese University of Hong Kong, New Territories, Hong Kong; junyu{at}cuhk.edu.hk The gut ...
gut.bmj2d
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Objective Autophagy participates in the progression of hepatocellular carcinoma (HCC) and the resistance of HCC cells to sorafenib. We investigated the feasibility of sensitising HCC cells to ...
gut.bmj5d
Stimulus and site specific induction of hiccups in the oesophagus of normal subjects
a Digestive Disease Research Center/Neuroenteric Biology Group, Department of Medicine, UCLA and West LA VA Medical Center, Los Angeles, California, USA, b Section of Gastroenterology (111G-1), Tucson ...
gut.bmj5d
PTU-084 Decompensated Cirrhosis in the Acute Medical Unit – A Neglected Group?
Introduction Decompensated chronic liver disease (DCLD) is a medical emergency with high mortality, usually managed by non-specialists in emergency (ED) and acute medical (AMU) departments in critical ...
gut.bmj7d
Maternal antibiotic exposure during pregnancy and risk of IBD in offspring: a population-based cohort study
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj7d
Impact of colorectal cancer in the UK
Colorectal (large bowel) cancer is the second commonest cause of cancer related death in the western world and there are more than 30 000 new cases per annum in the UK with an average five year ...